A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track ...

Over an 18-month follow-up, 102 (52.8%) VEN-O patients discontinued after completing the fixed-duration period; 597 (37.9%) BTKi and 57 (29.5%) VEN-O patients discontinued treatment prematurely. The ...

The marked underrepresentation of LMICs in leukemia clinical trials highlights the limited access to novel leukemia therapies in LMICs and raises concerns about the generalizability of clinical trial ...

Scientists in Japan have discovered a genetic "silencer" within the HTLV-1 virus that helps it stay hidden in the body, evading the immune system for decades. This silencer element essentially turns ...

Medically reviewed by Gagandeep Brar, MD Key Takeaways CMML is a rare form of leukemia that can cause extreme fatigue, easy ...

BUFFALO, N.Y. — A 6-year-old who was diagnosed with a rare form of leukemia is in remission and ready for first grade after receiving an innovative cancer treatment at Roswell Park Comprehensive Care ...

Inspired by her health journey, Coiro decided to work with patients who had blood cancers. In 2019, she became a stem cell ...